Pain Management Therapeutics Market - Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning / Landscape Review & Global Market Size Forecast to 2030
3.8%
CAGR (2024-2030)
78.9 USD Bn.
Market Size
326
Report Pages
153
Market Tables
Overview
Pain Management Therapeutics Market is expected to reach USD 102.44 Bn. at a CAGR of 3.8% during the forecast period 2030.
Pain management therapeutics help patients avoid spiraling into a public of chronic pain, or at minimum reduce the severity of pain. Minimally invasive procedures and proper use of medications are implemented to succeed in pain management goals between persons.
The growing number of people suffering from chronic disease, rising geriatric population and increasing incidence of chronic pain conditions will continue to encourage the use of pain management drugs are expected to drives in the global pain management therapeutics market. However, side effects caused by certain pain management therapeutics and low adoption in the emerging market is a dynamic restraining growth of the market. Moreover, increasing preference by the general population and ongoing research and development in the pain therapeutics are opportunities in the global market.
To know about the Research Methodology :- Request Free Sample Report
The report covers an in-depth analysis of driving factors, opportunities, and restraints for gaining the key insight of the market. The report emphasizes on all the key trends that play a significant role in the enlargement of the market from 2024 to 2030.
Based on the indication, the cancer pain segment is expected to dominate the xx% market share during the forecast period. Increased in the prevalence of cancer across the globe and an increase in healthcare expenditure universal have improved the evolution of the cancer pain segment. The rising occurrence of cancer and growing awareness about cancer pain therapeutics are the significant causes contributing to the growth cancer pain segment during the forecast period.
The online pharmacy segment dominates xx% market share during the forecast period, the increasing trend of online purchasing and growing digitalization are significant growth in the online pharmacies segment. The developed healthcare infrastructure and rising awareness among the user about the benefits of e-commerce are some of the factors dynamic the growth of the global market.
The Asia Pacific is expected to account for the largest share of the pain management therapeutics market during the forecast period. The implementation of advanced therapeutics and a large patient pool of chronic pain is expected to propel the development of the pain management therapeutics market in the Asia Pacific over the forecast period. The increasing number of untreated chronic diseases and developing government support to the available diagnosis and treatment facilities will encourage the use of pain management drugs thereby heavy the market during the forecast period.
The objective of the report is to present comprehensive analysis of global pain management therapeutics market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.
The report also helps in understanding global pain management therapeutics market dynamics, structure by analyzing the market segments, and project the global pain management therapeutics market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the global pain management therapeutics market make the report investor’s guide.
Global Pain Management Therapeutics Market Scope: Inquire before buying
| Global Pain Management Therapeutics Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2023 | Forecast Period: | 2024-2030 |
| Historical Data: | 2018 to 2023 | Market Size in 2023: | USD 78.90 Bn. |
| Forecast Period 2024 to 2030 CAGR: | 3.8% | Market Size in 2030: | USD 102.44 Bn. |
| Segments Covered: | by Drug Class | Anticonvulsants Antidepressants Anesthetics Non-steroidal Anti-inflammatory Drugs (NSAIDs) Opioids Antimigraine Agents Others |
|
| by Indication | Neuropathic Pain Fibromyalgia Chronic Back Pain Arthritic Pain Migraine Post-operative Pain Cancer Pain |
||
| by Distribution Channel | Hospitals Pharmacy Retail Pharmacy Online Pharmacy |
||
by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Global Pain Management Therapeutics Market Key players
1. Pfizer Inc.
2. Endo International Plc.
3. Depomed Inc.
4. Purdue Pharma L.P.
5. Teva Pharmaceutical Industries Ltd
6. Mallinckrodt Pharmaceuticals
7. AstraZeneca Plc
8. Novartis AG
9. Merck & Co. Inc.
10.Johnson & Johnson Services Inc.
11.GlaxoSmithKline Plc.
12.Abbott Laboratories.
13.Assertio Holdings, Inc.
14.Eli Lilly and Company
15.Viatris Inc.
16.Hisamitsu Pharmaceutical Co.,Inc.
17.CALMAR PAIN RELIEF, LLC
18.Calmare Therapeutics Incorporated
19.Allergan
20.F. Hoffmann-La Roche Ltd
Frequently Asked Questions:
1. Which region has the largest share in Global Pain Management Therapeutics Market?
Ans: Asia Pacific region holds the highest share in 2023.
2. What is the growth rate of Global Pain Management Therapeutics Market?
Ans: The Global Pain Management Therapeutics Market is growing at a CAGR of 3.8% during forecasting period 2024-2030.
3. What is scope of the Global Pain Management Therapeutics market report?
Ans: Global market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Pain Management Therapeutics market?
Ans: The important key players in the global market are – Pfizer Inc., Endo International Plc., Depomed Inc., Purdue Pharma L.P., Teva Pharmaceutical Industries Ltd, Mallinckrodt Pharmaceuticals, AstraZeneca Plc, Novartis AG, Merck & Co. Inc., Johnson & Johnson Services Inc., GlaxoSmithKline Plc., Abbott Laboratories., Assertio Holdings, Inc., Eli Lilly and Company, Viatris Inc., Hisamitsu Pharmaceutical Co.,Inc., CALMAR PAIN RELIEF, LLC, Calmare Therapeutics Incorporated, Allergan, and F. Hoffmann-La Roche Ltd
5. What is the study period of this market?
Ans: The Global Pain Management Therapeutics Market is studied from 2023 to 2030.
Table of Contents
Global Pain Management Therapeutics Market
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Global Pain Management Therapeutics Market Size, by Market Value (US$ Bn)
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies
5. Supply Side and Demand Side Indicators
6. Global Pain Management Therapeutics Market Analysis and Forecast
6.1. Global Pain Management Therapeutics Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America
7. Global Pain Management Therapeutics Market Analysis and Forecast, by Drug Class
7.1. Introduction and Definition
7.2. Key Findings
7.3. Global Pain Management Therapeutics Market Value Share Analysis, by Drug Class
7.4. Global Pain Management Therapeutics Market Size (US$ Bn) Forecast, by Drug Class
7.5. Global Pain Management Therapeutics Market Analysis, by Drug Class
7.6. Global Pain Management Therapeutics Market Attractiveness Analysis, by Drug Class
8. Global Pain Management Therapeutics Market Analysis and Forecast, by Indication
8.1. Introduction and Definition
8.2. Key Findings
8.3. Global Pain Management Therapeutics Market Value Share Analysis, by Indication
8.4. Global Pain Management Therapeutics Market Size (US$ Bn) Forecast, by Indication
8.5. Global Pain Management Therapeutics Market Analysis, by Indication
8.6. Global Pain Management Therapeutics Market Attractiveness Analysis, by Indication
9. Global Pain Management Therapeutics Market Analysis and Forecast, by Distribution Channel
9.1. Introduction and Definition
9.2. Key Findings
9.3. Global Pain Management Therapeutics Market Value Share Analysis, by Distribution Channel
9.4. Global Pain Management Therapeutics Market Size (US$ Bn) Forecast, by Distribution Channel
9.5. Global Pain Management Therapeutics Market Analysis, by Distribution Channel
9.6. Global Pain Management Therapeutics Market Attractiveness Analysis, by Distribution Channel
10. Global Pain Management Therapeutics Market Analysis, by Region
10.1. Global Pain Management Therapeutics Market Value Share Analysis, by Region
10.2. Global Pain Management Therapeutics Market Size (US$ Bn) Forecast, by Region
10.3. Global Pain Management Therapeutics Market Attractiveness Analysis, by Region
11. North America Pain Management Therapeutics Market Analysis
11.1. Key Findings
11.2. North America Pain Management Therapeutics Market Overview
11.3. North America Pain Management Therapeutics Market Value Share Analysis, by Drug Class
11.4. North America Pain Management Therapeutics Market Forecast, by Drug Class
11.4.1. Anticonvulsants
11.4.2. Antidepressants
11.4.3. Anesthetics
11.4.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
11.4.5. Opioids
11.4.5.1. Oxycodones
11.4.5.2. Hydrocodones
11.4.5.3. Tramadol
11.4.5.4. Others
11.4.6. Antimigraine Agents
11.4.7. Others
11.5. North America Pain Management Therapeutics Market Value Share Analysis, by Indication
11.6. North America Pain Management Therapeutics Market Forecast, by Indication
11.6.1. Neuropathic Pain
11.6.2. Fibromyalgia
11.6.3. Chronic Back Pain
11.6.4. Arthritic Pain
11.6.5. Migraine
11.6.6. Post-operative Pain
11.6.7. Cancer Pain
11.7. North America Pain Management Therapeutics Market Value Share Analysis, by Distribution Channel
11.8. North America Pain Management Therapeutics Market Forecast, by Distribution Channel
11.8.1. Hospitals Pharmacy
11.8.2. Retail Pharmacy
11.8.3. Online Pharmacy
11.9. North America Pain Management Therapeutics Market Value Share Analysis, by Country
11.10. North America Pain Management Therapeutics Market Forecast, by Country
11.10.1. U.S.
11.10.2. Canada
11.11. North America Pain Management Therapeutics Market Analysis, by Country
11.12. U.S. Pain Management Therapeutics Market Forecast, by Drug Class
11.12.1. Anticonvulsants
11.12.2. Antidepressants
11.12.3. Anesthetics
11.12.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
11.12.5. Opioids
11.12.5.1. Oxycodones
11.12.5.2. Hydrocodones
11.12.5.3. Tramadol
11.12.5.4. Others
11.12.6. Antimigraine Agents
11.12.7. Others
11.13. U.S. Pain Management Therapeutics Market Forecast, by Indication
11.13.1. Neuropathic Pain
11.13.2. Fibromyalgia
11.13.3. Chronic Back Pain
11.13.4. Arthritic Pain
11.13.5. Migraine
11.13.6. Post-operative Pain
11.13.7. Cancer Pain
11.14. U.S. Pain Management Therapeutics Market Forecast, by Distribution Channel
11.14.1. Hospitals Pharmacy
11.14.2. Retail Pharmacy
11.14.3. Online Pharmacy
11.15. Canada Pain Management Therapeutics Market Forecast, by Drug Class
11.15.1. Anticonvulsants
11.15.2. Antidepressants
11.15.3. Anesthetics
11.15.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
11.15.5. Opioids
11.15.5.1. Oxycodones
11.15.5.2. Hydrocodones
11.15.5.3. Tramadol
11.15.5.4. Others
11.15.6. Antimigraine Agents
11.15.7. Others
11.16. Canada Pain Management Therapeutics Market Forecast, by Indication
11.16.1. Neuropathic Pain
11.16.2. Fibromyalgia
11.16.3. Chronic Back Pain
11.16.4. Arthritic Pain
11.16.5. Migraine
11.16.6. Post-operative Pain
11.16.7. Cancer Pain
11.17. Canada Pain Management Therapeutics Market Forecast, by Distribution Channel
11.17.1. Hospitals Pharmacy
11.17.2. Retail Pharmacy
11.17.3. Online Pharmacy
11.18. North America Pain Management Therapeutics Market Attractiveness Analysis
11.18.1. By Drug Class
11.18.2. By Indication
11.18.3. By Distribution Channel
11.19. PEST Analysis
11.20. Key Trends
11.21. Key Developments
12. Europe Pain Management Therapeutics Market Analysis
12.1. Key Findings
12.2. Europe Pain Management Therapeutics Market Overview
12.3. Europe Pain Management Therapeutics Market Value Share Analysis, by Drug Class
12.4. Europe Pain Management Therapeutics Market Forecast, by Drug Class
12.4.1. Anticonvulsants
12.4.2. Antidepressants
12.4.3. Anesthetics
12.4.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
12.4.5. Opioids
12.4.5.1. Oxycodones
12.4.5.2. Hydrocodones
12.4.5.3. Tramadol
12.4.5.4. Others
12.4.6. Antimigraine Agents
12.4.7. Others
12.5. Europe Pain Management Therapeutics Market Value Share Analysis, by Indication
12.6. Europe Pain Management Therapeutics Market Forecast, by Indication
12.6.1. Neuropathic Pain
12.6.2. Fibromyalgia
12.6.3. Chronic Back Pain
12.6.4. Arthritic Pain
12.6.5. Migraine
12.6.6. Post-operative Pain
12.6.7. Cancer Pain
12.7. Europe Pain Management Therapeutics Market Value Share Analysis, by Distribution Channel
12.8. Europe Pain Management Therapeutics Market Forecast, by Distribution Channel
12.8.1. Hospitals Pharmacy
12.8.2. Retail Pharmacy
12.8.3. Online Pharmacy
12.9. Europe Pain Management Therapeutics Market Value Share Analysis, by Country
12.10. Europe Pain Management Therapeutics Market Forecast, by Country
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Europe Pain Management Therapeutics Market Analysis, by Country
12.12. Europe Pain Management Therapeutics Market Forecast, by Drug Class
12.12.1. Anticonvulsants
12.12.2. Antidepressants
12.12.3. Anesthetics
12.12.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
12.12.5. Opioids
12.12.5.1. Oxycodones
12.12.5.2. Hydrocodones
12.12.5.3. Tramadol
12.12.5.4. Others
12.12.6. Antimigraine Agents
12.12.7. Others
12.13. Germany Pain Management Therapeutics Market Forecast, by Indication
12.13.1. Neuropathic Pain
12.13.2. Fibromyalgia
12.13.3. Chronic Back Pain
12.13.4. Arthritic Pain
12.13.5. Migraine
12.13.6. Post-operative Pain
12.13.7. Cancer Pain
12.14. Germany Pain Management Therapeutics Market Forecast, by Distribution Channel
12.14.1. Hospitals Pharmacy
12.14.2. Retail Pharmacy
12.14.3. Online Pharmacy
12.15. U.K. Pain Management Therapeutics Market Forecast, by Drug Class
12.15.1. Anticonvulsants
12.15.2. Antidepressants
12.15.3. Anesthetics
12.15.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
12.15.5. Opioids
12.15.5.1. Oxycodones
12.15.5.2. Hydrocodones
12.15.5.3. Tramadol
12.15.5.4. Others
12.15.6. Antimigraine Agents
12.15.7. Others
12.16. U.K. Pain Management Therapeutics Market Forecast, by Indication
12.16.1. Neuropathic Pain
12.16.2. Fibromyalgia
12.16.3. Chronic Back Pain
12.16.4. Arthritic Pain
12.16.5. Migraine
12.16.6. Post-operative Pain
12.16.7. Cancer Pain
12.17. U.K. Pain Management Therapeutics Market Forecast, by Distribution Channel
12.17.1. Hospitals Pharmacy
12.17.2. Retail Pharmacy
12.17.3. Online Pharmacy
12.18. France Pain Management Therapeutics Market Forecast, by Drug Class
12.18.1. Anticonvulsants
12.18.2. Antidepressants
12.18.3. Anesthetics
12.18.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
12.18.5. Opioids
12.18.5.1. Oxycodones
12.18.5.2. Hydrocodones
12.18.5.3. Tramadol
12.18.5.4. Others
12.18.6. Antimigraine Agents
12.18.7. Others
12.19. France Pain Management Therapeutics Market Forecast, by Indication
12.19.1. Neuropathic Pain
12.19.2. Fibromyalgia
12.19.3. Chronic Back Pain
12.19.4. Arthritic Pain
12.19.5. Migraine
12.19.6. Post-operative Pain
12.19.7. Cancer Pain
12.20. France Pain Management Therapeutics Market Forecast, by Distribution Channel
12.20.1. Hospitals Pharmacy
12.20.2. Retail Pharmacy
12.20.3. Online Pharmacy
12.21. Italy Pain Management Therapeutics Market Forecast, by Drug Class
12.21.1. Anticonvulsants
12.21.2. Antidepressants
12.21.3. Anesthetics
12.21.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
12.21.5. Opioids
12.21.5.1. Oxycodones
12.21.5.2. Hydrocodones
12.21.5.3. Tramadol
12.21.5.4. Others
12.21.6. Antimigraine Agents
12.21.7. Others
12.22. Italy Pain Management Therapeutics Market Forecast, by Indication
12.22.1. Neuropathic Pain
12.22.2. Fibromyalgia
12.22.3. Chronic Back Pain
12.22.4. Arthritic Pain
12.22.5. Migraine
12.22.6. Post-operative Pain
12.22.7. Cancer Pain
12.23. Italy Pain Management Therapeutics Market Forecast, by Distribution Channel
12.23.1. Hospitals Pharmacy
12.23.2. Retail Pharmacy
12.23.3. Online Pharmacy
12.24. Spain Pain Management Therapeutics Market Forecast, by Drug Class
12.24.1. Anticonvulsants
12.24.2. Antidepressants
12.24.3. Anesthetics
12.24.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
12.24.5. Opioids
12.24.5.1. Oxycodones
12.24.5.2. Hydrocodones
12.24.5.3. Tramadol
12.24.5.4. Others
12.24.6. Antimigraine Agents
12.24.7. Others
12.25. Spain Pain Management Therapeutics Market Forecast, by Indication
12.25.1. Neuropathic Pain
12.25.2. Fibromyalgia
12.25.3. Chronic Back Pain
12.25.4. Arthritic Pain
12.25.5. Migraine
12.25.6. Post-operative Pain
12.25.7. Cancer Pain
12.26. Spain Pain Management Therapeutics Market Forecast, by Distribution Channel
12.26.1. Hospitals Pharmacy
12.26.2. Retail Pharmacy
12.26.3. Online Pharmacy
12.27. Rest of Europe Pain Management Therapeutics Market Forecast, by Drug Class
12.27.1. Anticonvulsants
12.27.2. Antidepressants
12.27.3. Anesthetics
12.27.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
12.27.5. Opioids
12.27.5.1. Oxycodones
12.27.5.2. Hydrocodones
12.27.5.3. Tramadol
12.27.5.4. Others
12.27.6. Antimigraine Agents
12.27.7. Others
12.28. Rest of Europe Pain Management Therapeutics Market Forecast, by Indication
12.28.1. Neuropathic Pain
12.28.2. Fibromyalgia
12.28.3. Chronic Back Pain
12.28.4. Arthritic Pain
12.28.5. Migraine
12.28.6. Post-operative Pain
12.28.7. Cancer Pain
12.29. Rest Of Europe Pain Management Therapeutics Market Forecast, by Distribution Channel
12.29.1. Hospitals Pharmacy
12.29.2. Retail Pharmacy
12.29.3. Online Pharmacy
12.30. Europe Pain Management Therapeutics Market Attractiveness Analysis
12.30.1. By Drug Class
12.30.2. By Indication
12.30.3. By Distribution Channel
12.31. PEST Analysis
12.32. Key Trends
12.33. Key Developments
13. Asia Pacific Pain Management Therapeutics Market Analysis
13.1. Key Findings
13.2. Asia Pacific Pain Management Therapeutics Market Overview
13.3. Asia Pacific Pain Management Therapeutics Market Value Share Analysis, by Drug Class
13.4. Asia Pacific Pain Management Therapeutics Market Forecast, by Drug Class
13.4.1. Anticonvulsants
13.4.2. Antidepressants
13.4.3. Anesthetics
13.4.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
13.4.5. Opioids
13.4.5.1. Oxycodones
13.4.5.2. Hydrocodones
13.4.5.3. Tramadol
13.4.5.4. Others
13.4.6. Antimigraine Agents
13.4.7. Others
13.5. Asia Pacific Pain Management Therapeutics Market Value Share Analysis, By Indication
13.6. Asia Pacific Pain Management Therapeutics Market Forecast, by Indication
13.6.1. Neuropathic Pain
13.6.2. Fibromyalgia
13.6.3. Chronic Back Pain
13.6.4. Arthritic Pain
13.6.5. Migraine
13.6.6. Post-operative Pain
13.6.7. Cancer Pain
13.7. Asia Pacific Pain Management Therapeutics Market Value Share Analysis, by Distribution Channel
13.8. Asia Pacific Pain Management Therapeutics Market Forecast, by Distribution Channel
13.8.1. Hospitals Pharmacy
13.8.2. Retail Pharmacy
13.8.3. Online Pharmacy
13.9. Asia Pacific Pain Management Therapeutics Market Value Share Analysis, by Country
13.10. Asia Pacific Pain Management Therapeutics Market Forecast, by Country
13.10.1. China
13.10.2. India
13.10.3. Japan
13.10.4. ASEAN
13.10.5. Rest of Asia Pacific
13.11. Asia Pacific Pain Management Therapeutics Market Analysis, by Country
13.12. China Pain Management Therapeutics Market Forecast, by Drug Class
13.12.1. Anticonvulsants
13.12.2. Antidepressants
13.12.3. Anesthetics
13.12.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
13.12.5. Opioids
13.12.5.1. Oxycodones
13.12.5.2. Hydrocodones
13.12.5.3. Tramadol
13.12.5.4. Others
13.12.6. Antimigraine Agents
13.12.7. Others
13.13. China Pain Management Therapeutics Market Forecast, by Indication
13.13.1. Neuropathic Pain
13.13.2. Fibromyalgia
13.13.3. Chronic Back Pain
13.13.4. Arthritic Pain
13.13.5. Migraine
13.13.6. Post-operative Pain
13.13.7. Cancer Pain
13.14. China Pain Management Therapeutics Market Forecast, by Distribution Channel
13.14.1. Hospitals Pharmacy
13.14.2. Retail Pharmacy
13.14.3. Online Pharmacy
13.15. India Pain Management Therapeutics Market Forecast, by Drug Class
13.15.1. Anticonvulsants
13.15.2. Antidepressants
13.15.3. Anesthetics
13.15.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
13.15.5. Opioids
13.15.5.1. Oxycodones
13.15.5.2. Hydrocodones
13.15.5.3. Tramadol
13.15.5.4. Others
13.15.6. Antimigraine Agents
13.15.7. Others
13.16. India Pain Management Therapeutics Market Forecast, by Indication
13.16.1. Neuropathic Pain
13.16.2. Fibromyalgia
13.16.3. Chronic Back Pain
13.16.4. Arthritic Pain
13.16.5. Migraine
13.16.6. Post-operative Pain
13.16.7. Cancer Pain
13.17. India Pain Management Therapeutics Market Forecast, by Distribution Channel
13.17.1. Hospitals Pharmacy
13.17.2. Retail Pharmacy
13.17.3. Online Pharmacy
13.18. Japan Pain Management Therapeutics Market Forecast, by Drug Class
13.18.1. Anticonvulsants
13.18.2. Antidepressants
13.18.3. Anesthetics
13.18.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
13.18.5. Opioids
13.18.5.1. Oxycodones
13.18.5.2. Hydrocodones
13.18.5.3. Tramadol
13.18.5.4. Others
13.18.6. Antimigraine Agents
13.18.7. Others
13.19. Japan Pain Management Therapeutics Market Forecast, by Indication
13.19.1. Neuropathic Pain
13.19.2. Fibromyalgia
13.19.3. Chronic Back Pain
13.19.4. Arthritic Pain
13.19.5. Migraine
13.19.6. Post-operative Pain
13.19.7. Cancer Pain
13.20. Japan Pain Management Therapeutics Market Forecast, by Distribution Channel
13.20.1. Hospitals Pharmacy
13.20.2. Retail Pharmacy
13.20.3. Online Pharmacy
13.21. ASEAN Pain Management Therapeutics Market Forecast, by Drug Class
13.21.1. Anticonvulsants
13.21.2. Antidepressants
13.21.3. Anesthetics
13.21.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
13.21.5. Opioids
13.21.5.1. Oxycodones
13.21.5.2. Hydrocodones
13.21.5.3. Tramadol
13.21.5.4. Others
13.21.6. Antimigraine Agents
13.21.7. Others
13.22. ASEAN Pain Management Therapeutics Market Forecast, by Indication
13.22.1. Neuropathic Pain
13.22.2. Fibromyalgia
13.22.3. Chronic Back Pain
13.22.4. Arthritic Pain
13.22.5. Migraine
13.22.6. Post-operative Pain
13.22.7. Cancer Pain
13.23. ASEAN Pain Management Therapeutics Market Forecast, by Distribution Channel
13.23.1. Hospitals Pharmacy
13.23.2. Retail Pharmacy
13.23.3. Online Pharmacy
13.24. Rest of Asia Pacific Pain Management Therapeutics Market Forecast, by Drug Class
13.24.1. Anticonvulsants
13.24.2. Antidepressants
13.24.3. Anesthetics
13.24.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
13.24.5. Opioids
13.24.5.1. Oxycodones
13.24.5.2. Hydrocodones
13.24.5.3. Tramadol
13.24.5.4. Others
13.24.6. Antimigraine Agents
13.24.7. Others
13.25. Rest of Asia Pacific Pain Management Therapeutics Market Forecast, by Indication
13.25.1. Neuropathic Pain
13.25.2. Fibromyalgia
13.25.3. Chronic Back Pain
13.25.4. Arthritic Pain
13.25.5. Migraine
13.25.6. Post-operative Pain
13.25.7. Cancer Pain
13.26. Rest of Asia Pacific Pain Management Therapeutics Market Forecast, by Distribution Channel
13.26.1. Hospitals Pharmacy
13.26.2. Retail Pharmacy
13.26.3. Online Pharmacy
13.27. Asia Pacific Pain Management Therapeutics Market Attractiveness Analysis
13.27.1. By Drug Class
13.27.2. By Indication
13.27.3. By Distribution Channel
13.28. PEST Analysis
13.29. Key Trends
13.30. Key Developments
14. Middle East & Africa Pain Management Therapeutics Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Pain Management Therapeutics Market Overview
14.3. Middle East & Africa Pain Management Therapeutics Market Value Share Analysis, by Drug Class
14.4. Middle East & Africa Pain Management Therapeutics Market Forecast, by Drug Class
14.4.1. Anticonvulsants
14.4.2. Antidepressants
14.4.3. Anesthetics
14.4.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
14.4.5. Opioids
14.4.5.1. Oxycodones
14.4.5.2. Hydrocodones
14.4.5.3. Tramadol
14.4.5.4. Others
14.4.6. Antimigraine Agents
14.4.7. Others
14.5. Middle East & Africa Pain Management Therapeutics Market Value Share Analysis, By Indication
14.6. Middle East & Africa Pain Management Therapeutics Market Forecast, by Indication
14.6.1. Neuropathic Pain
14.6.2. Fibromyalgia
14.6.3. Chronic Back Pain
14.6.4. Arthritic Pain
14.6.5. Migraine
14.6.6. Post-operative Pain
14.6.7. Cancer Pain
14.7. Middle East & Africa Pain Management Therapeutics Market Value Share Analysis, by Distribution Channel
14.8. Middle East & Africa Pain Management Therapeutics Market Forecast, by Distribution Channel
14.8.1. Hospitals Pharmacy
14.8.2. Retail Pharmacy
14.8.3. Online Pharmacy
14.9. Middle East & Africa Pain Management Therapeutics Market Value Share Analysis, by Country
14.10. Middle East & Africa Pain Management Therapeutics Market Forecast, by Country
14.10.1. GCC
14.10.2. South Africa
14.10.3. Rest of Middle East & Africa
14.11. Middle East & Africa Pain Management Therapeutics Market Analysis, by Country
14.12. GCC Pain Management Therapeutics Market Forecast, by Drug Class
14.12.1. Anticonvulsants
14.12.2. Antidepressants
14.12.3. Anesthetics
14.12.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
14.12.5. Opioids
14.12.5.1. Oxycodones
14.12.5.2. Hydrocodones
14.12.5.3. Tramadol
14.12.5.4. Others
14.12.6. Antimigraine Agents
14.12.7. Others
14.13. GCC Pain Management Therapeutics Market Forecast, by Indication
14.13.1. Neuropathic Pain
14.13.2. Fibromyalgia
14.13.3. Chronic Back Pain
14.13.4. Arthritic Pain
14.13.5. Migraine
14.13.6. Post-operative Pain
14.13.7. Cancer Pain
14.14. GCC Pain Management Therapeutics Market Forecast, by Distribution Channel
14.14.1. Hospitals Pharmacy
14.14.2. Retail Pharmacy
14.14.3. Online Pharmacy
14.15. South Africa Pain Management Therapeutics Market Forecast, by Drug Class
14.15.1. Anticonvulsants
14.15.2. Antidepressants
14.15.3. Anesthetics
14.15.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
14.15.5. Opioids
14.15.5.1. Oxycodones
14.15.5.2. Hydrocodones
14.15.5.3. Tramadol
14.15.5.4. Others
14.15.6. Antimigraine Agents
14.15.7. Others
14.16. South Africa Pain Management Therapeutics Market Forecast, by Indication
14.16.1. Neuropathic Pain
14.16.2. Fibromyalgia
14.16.3. Chronic Back Pain
14.16.4. Arthritic Pain
14.16.5. Migraine
14.16.6. Post-operative Pain
14.16.7. Cancer Pain
14.17. South Africa Pain Management Therapeutics Market Forecast, by Distribution Channel
14.17.1. Hospitals Pharmacy
14.17.2. Retail Pharmacy
14.17.3. Online Pharmacy
14.18. Rest of Middle East & Africa Pain Management Therapeutics Market Forecast, by Drug Class
14.18.1. Anticonvulsants
14.18.2. Antidepressants
14.18.3. Anesthetics
14.18.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
14.18.5. Opioids
14.18.5.1. Oxycodones
14.18.5.2. Hydrocodones
14.18.5.3. Tramadol
14.18.5.4. Others
14.18.6. Antimigraine Agents
14.18.7. Others
14.19. Rest of Middle East & Africa Pain Management Therapeutics Market Forecast, by Indication
14.19.1. Neuropathic Pain
14.19.2. Fibromyalgia
14.19.3. Chronic Back Pain
14.19.4. Arthritic Pain
14.19.5. Migraine
14.19.6. Post-operative Pain
14.19.7. Cancer Pain
14.20. Rest of Middle East & Africa Pain Management Therapeutics Market Forecast, by Distribution Channel
14.20.1. Hospitals Pharmacy
14.20.2. Retail Pharmacy
14.20.3. Online Pharmacy
14.21. Middle East & Africa Pain Management Therapeutics Market Attractiveness Analysis
14.21.1.1. By Drug Class
14.21.1.2. By Indication
14.21.1.3. By Distribution Channel
14.21.1.4. PEST Analysis
14.21.1.5. Key Trends
14.21.1.6. Key Developments
15. South America Pain Management Therapeutics Market Analysis
15.1. Key Findings
15.2. South America Pain Management Therapeutics Market Overview
15.3. South America Pain Management Therapeutics Market Value Share Analysis, by Drug Class
15.4. South America Pain Management Therapeutics Market Forecast, by Drug Class
15.4.1. Anticonvulsants
15.4.2. Antidepressants
15.4.3. Anesthetics
15.4.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
15.4.5. Opioids
15.4.5.1. Oxycodones
15.4.5.2. Hydrocodones
15.4.5.3. Tramadol
15.4.5.4. Others
15.4.6. Antimigraine Agents
15.4.7. Others
15.5. South America Pain Management Therapeutics Market Value Share Analysis, By Indication
15.6. South America Pain Management Therapeutics Market Forecast, by Indication
15.6.1. Neuropathic Pain
15.6.2. Fibromyalgia
15.6.3. Chronic Back Pain
15.6.4. Arthritic Pain
15.6.5. Migraine
15.6.6. Post-operative Pain
15.6.7. Cancer Pain
15.7. South America Pain Management Therapeutics Market Value Share Analysis, by Distribution Channel
15.8. South America Pain Management Therapeutics Market Forecast, by Distribution Channel
15.8.1. Hospitals Pharmacy
15.8.2. Retail Pharmacy
15.8.3. Online Pharmacy
15.9. South America Pain Management Therapeutics Market Value Share Analysis, by Country
15.10. South America Pain Management Therapeutics Market Forecast, by Country
15.10.1. Brazil
15.10.2. Mexico
15.10.3. Rest of South America
15.11. South America Pain Management Therapeutics Market Analysis, by Country
15.12. Processing Equipment Forecast, by Drug Class
15.12.1. Anticonvulsants
15.12.2. Antidepressants
15.12.3. Anesthetics
15.12.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
15.12.5. Opioids
15.12.5.1. Oxycodones
15.12.5.2. Hydrocodones
15.12.5.3. Tramadol
15.12.5.4. Others
15.12.6. Antimigraine Agents
15.12.7. Others
15.13. Brazil Pain Management Therapeutics Market Forecast, by Indication
15.13.1. Neuropathic Pain
15.13.2. Fibromyalgia
15.13.3. Chronic Back Pain
15.13.4. Arthritic Pain
15.13.5. Migraine
15.13.6. Post-operative Pain
15.13.7. Cancer Pain
15.14. Brazil Pain Management Therapeutics Market Forecast, by Distribution Channel
15.14.1. Hospitals Pharmacy
15.14.2. Retail Pharmacy
15.14.3. Online Pharmacy
15.15. Mexico Pain Management Therapeutics Market Forecast, by Drug Class
15.15.1. Anticonvulsants
15.15.2. Antidepressants
15.15.3. Anesthetics
15.15.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
15.15.5. Opioids
15.15.5.1. Oxycodones
15.15.5.2. Hydrocodones
15.15.5.3. Tramadol
15.15.5.4. Others
15.15.6. Antimigraine Agents
15.15.7. Others
15.16. Mexico Pain Management Therapeutics Market Forecast, by Indication
15.16.1. Neuropathic Pain
15.16.2. Fibromyalgia
15.16.3. Chronic Back Pain
15.16.4. Arthritic Pain
15.16.5. Migraine
15.16.6. Post-operative Pain
15.16.7. Cancer Pain
15.17. Mexico Pain Management Therapeutics Market Forecast, by Distribution Channel
15.17.1. Hospitals Pharmacy
15.17.2. Retail Pharmacy
15.17.3. Online Pharmacy
15.18. Rest of South America Pain Management Therapeutics Market Forecast, by Drug Class
15.18.1. Anticonvulsants
15.18.2. Antidepressants
15.18.3. Anesthetics
15.18.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
15.18.5. Opioids
15.18.5.1. Oxycodones
15.18.5.2. Hydrocodones
15.18.5.3. Tramadol
15.18.5.4. Others
15.18.6. Antimigraine Agents
15.18.7. Others
15.19. Rest of South America Pain Management Therapeutics Market Forecast, by Indication
15.19.1. Neuropathic Pain
15.19.2. Fibromyalgia
15.19.3. Chronic Back Pain
15.19.4. Arthritic Pain
15.19.5. Migraine
15.19.6. Post-operative Pain
15.19.7. Cancer Pain
15.20. Rest of South America Pain Management Therapeutics Market Forecast, by Distribution Channel
15.20.1. Hospitals Pharmacy
15.20.2. Retail Pharmacy
15.20.3. Online Pharmacy
15.21. South America Pain Management Therapeutics Market Attractiveness Analysis
15.21.1. By Drug Class
15.21.2. By Indication
15.21.3. By Distribution Channel
15.22. PEST Analysis
15.23. Key Trends
15.24. Key Developments
16. Company Profiles
16.1. Market Share Analysis, by Company
16.2. Competition Matrix
16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
16.2.2. New Product Launches and Product Enhancements
16.2.3. Market Consolidation
16.2.3.1. M&A by Regions, Investment and Applications
16.2.3.2. M&A Key Players, Forward Integration and Backward
Integration
16.3. Company Profiles: Key Players
16.3.1. Pfizer Inc.
16.3.1.1. Company Overview
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. Business Strategy
16.3.1.5. Recent Developments
16.3.1.6. Development Footprint
16.3.2. Endo International Plc.
16.3.3. Depomed Inc.
16.3.4. Purdue Pharma L.P.
16.3.5. Teva Pharmaceutical Industries Ltd
16.3.6. Mallinckrodt Pharmaceuticals
16.3.7. AstraZeneca Plc
16.3.8. Novartis AG
16.3.9. Merck & Co. Inc.
16.3.10. Johnson & Johnson Services Inc.
16.3.11. GlaxoSmithKline Plc.
16.3.12. Abbott Laboratories.
16.3.13. Assertio Holdings, Inc.
16.3.14. Eli Lilly and Company
16.3.15. Viatris Inc.
16.3.16. Hisamitsu Pharmaceutical Co.,Inc.
16.3.17. CALMAR PAIN RELIEF, LLC
16.3.18. Calmare Therapeutics Incorporated
16.3.19. Allergan
16.3.20. F. Hoffmann-La Roche Ltd
17. Primary Key Insights